The alliance extends a deal streak in genetic medicine for Lilly and hands the company rights to an experimental treatment ...

Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...

Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its laruparetigene zovaparvovec (laru-zova), a gene therapy that proved early improvements ...

Color blindness, or color vision deficiency, is more common in males. This is due to how parents pass down a chromosome associated with the male sex. Red-green color vision deficiency is the most ...

(CNN) — For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not ...

In a groundbreaking study, scientists from the Texas A&M College of Veterinary Medicine and Biomedical Sciences (VMBS) have ...

Please provide your email address to receive an email when new articles are posted on . Atsena Therapeutics completed patient dosing in part A of the phase 1/2 LIGHTHOUSE clinical trial investigating ...

Multiple sclerosis is an autoimmune and neurological disorder that strikes women about three times as often as men. There are many suspected causes of MS, including environmental factors (that may be ...

Most individuals with color vision deficiency have had it since birth. However, people can develop it later in life. If it develops due to a health problem, color blindness can worsen over time. Color ...